Companies / BOC Sciences / Rontalizumab
BOC Sciences

Rontalizumab | BOC Sciences

Rontalizumab is a human IgG1 monoclonal antibody that targets human IFN-a. Rontalizumab has been used in the research of Systemic Lupus Erythematosus treatment.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.